Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1989 1
1990 2
1991 2
1993 1
1995 2
1996 1
1997 5
1998 1
1999 1
2000 1
2001 2
2002 2
2003 5
2004 5
2005 7
2006 3
2007 8
2008 6
2009 3
2010 2
2011 2
2012 3
2013 5
2014 2
2015 6
2016 2
2017 2
2018 1
2019 2
2020 3
2021 1
2022 5
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

81 results

Results by year

Filters applied: . Clear all
Page 1
Discovery of new biomarkers for malignant mesothelioma.
Creaney J, Dick IM, Robinson BW. Creaney J, et al. Among authors: dick im. Curr Pulmonol Rep. 2015;4(1):15-21. doi: 10.1007/s13665-015-0106-8. Curr Pulmonol Rep. 2015. PMID: 25927434 Free PMC article. Review.
Comprehensive genomic and tumour immune profiling reveals potential therapeutic targets in malignant pleural mesothelioma.
Creaney J, Patch AM, Addala V, Sneddon SA, Nones K, Dick IM, Lee YCG, Newell F, Rouse EJ, Naeini MM, Kondrashova O, Lakis V, Nakas A, Waller D, Sharkey A, Mukhopadhyay P, Kazakoff SH, Koufariotis LT, Davidson AL, Ramarao-Milne P, Holmes O, Xu Q, Leonard C, Wood S, Grimmond SM, Bueno R, Fennell DA, Pearson JV, Robinson BW, Waddell N. Creaney J, et al. Among authors: dick im. Genome Med. 2022 May 30;14(1):58. doi: 10.1186/s13073-022-01060-8. Genome Med. 2022. PMID: 35637530 Free PMC article.
Combination immune checkpoint blockade as an effective therapy for mesothelioma.
Fear VS, Tilsed C, Chee J, Forbes CA, Casey T, Solin JN, Lansley SM, Lesterhuis WJ, Dick IM, Nowak AK, Robinson BW, Lake RA, Fisher SA. Fear VS, et al. Among authors: dick im. Oncoimmunology. 2018 Jul 30;7(10):e1494111. doi: 10.1080/2162402X.2018.1494111. eCollection 2018. Oncoimmunology. 2018. PMID: 30288361 Free PMC article.
BAP1 Loss by Immunohistochemistry Predicts Improved Survival to First-Line Platinum and Pemetrexed Chemotherapy for Patients With Pleural Mesothelioma: A Validation Study.
Louw A, Panou V, Szejniuk WM, Meristoudis C, Chai SM, van Vliet C, Lee YCG, Dick IM, Firth T, Lynggaard LA, Asghari AB, Vyberg M, Hansen J, Creaney J, Røe OD. Louw A, et al. Among authors: dick im. J Thorac Oncol. 2022 Jul;17(7):921-930. doi: 10.1016/j.jtho.2022.04.008. Epub 2022 Apr 27. J Thorac Oncol. 2022. PMID: 35489694 Free article.
81 results